(0.10%) 5 474.94 points
(0.11%) 39 153 points
(0.43%) 17 793 points
(-0.20%) $80.67
(-3.66%) $2.66
(-0.77%) $2 312.80
(0.18%) $28.92
(3.45%) $1 020.40
(0.28%) $0.936
(0.70%) $10.68
(0.45%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways...
Stats | |
---|---|
今日成交量 | 126 511 |
平均成交量 | 532 841 |
市值 | 129.24M |
EPS | $-0.230 ( Q1 | 2024-05-15 ) |
下一个收益日期 | ( $-0.340 ) 2024-08-19 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-4.65 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00900 (0.22%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-05 | Walbert Timothy P | Buy | 9 279 | Stock Option (Right to Buy) |
2024-06-05 | Seidenberg Beth C | Buy | 51 459 | Stock Option (Right to Buy) |
2024-06-05 | Parsey Merdad | Buy | 51 459 | Stock Option (Right to Buy) |
2024-06-05 | Hoelscher Paul W. | Buy | 9 279 | Stock Option (Right to Buy) |
2024-06-05 | Grammer Elizabeth A | Buy | 51 459 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
-96.24 |
Last 39 transactions |
Buy: 5 086 661 | Sell: 305 517 947 |
音量 相关性
Sagimet Biosciences Inc. 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Sagimet Biosciences Inc. 相关性 - 货币/商品
Sagimet Biosciences Inc. 财务报表
Annual | 2023 |
营收: | $2.00M |
毛利润: | $2.00M (100.00 %) |
EPS: | $-1.180 |
FY | 2023 |
营收: | $2.00M |
毛利润: | $2.00M (100.00 %) |
EPS: | $-1.180 |
FY | 2022 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $-1.380 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Sagimet Biosciences Inc.
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。